Medical Care
Global Antipsychotic Medicine Market Research Report 2025
- Mar 11, 25
- ID: 77678
- Pages: 82
- Figures: 82
- Views: 34
The global market for Antipsychotic Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medicine.
The Antipsychotic Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antipsychotic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Otsuka Pharma
Sumitomo Dainippon
Alkermes
Vanda Pharma
Segment by Type
Oral Antipsychotics
Injectable Antipsychotics
Segment by Application
Hospital Pharmacy
Clinic Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipsychotic Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medicine.
The Antipsychotic Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antipsychotic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Otsuka Pharma
Sumitomo Dainippon
Alkermes
Vanda Pharma
Segment by Type
Oral Antipsychotics
Injectable Antipsychotics
Segment by Application
Hospital Pharmacy
Clinic Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipsychotic Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipsychotic Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Antipsychotics
1.2.3 Injectable Antipsychotics
1.3 Market by Application
1.3.1 Global Antipsychotic Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Clinic Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Medicine Market Perspective (2020-2031)
2.2 Global Antipsychotic Medicine Growth Trends by Region
2.2.1 Global Antipsychotic Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antipsychotic Medicine Historic Market Size by Region (2020-2025)
2.2.3 Antipsychotic Medicine Forecasted Market Size by Region (2026-2031)
2.3 Antipsychotic Medicine Market Dynamics
2.3.1 Antipsychotic Medicine Industry Trends
2.3.2 Antipsychotic Medicine Market Drivers
2.3.3 Antipsychotic Medicine Market Challenges
2.3.4 Antipsychotic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipsychotic Medicine Players by Revenue
3.1.1 Global Top Antipsychotic Medicine Players by Revenue (2020-2025)
3.1.2 Global Antipsychotic Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Antipsychotic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antipsychotic Medicine Revenue
3.4 Global Antipsychotic Medicine Market Concentration Ratio
3.4.1 Global Antipsychotic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Medicine Revenue in 2024
3.5 Global Key Players of Antipsychotic Medicine Head office and Area Served
3.6 Global Key Players of Antipsychotic Medicine, Product and Application
3.7 Global Key Players of Antipsychotic Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Medicine Breakdown Data by Type
4.1 Global Antipsychotic Medicine Historic Market Size by Type (2020-2025)
4.2 Global Antipsychotic Medicine Forecasted Market Size by Type (2026-2031)
5 Antipsychotic Medicine Breakdown Data by Application
5.1 Global Antipsychotic Medicine Historic Market Size by Application (2020-2025)
5.2 Global Antipsychotic Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antipsychotic Medicine Market Size (2020-2031)
6.2 North America Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antipsychotic Medicine Market Size by Country (2020-2025)
6.4 North America Antipsychotic Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antipsychotic Medicine Market Size (2020-2031)
7.2 Europe Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antipsychotic Medicine Market Size by Country (2020-2025)
7.4 Europe Antipsychotic Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Medicine Market Size (2020-2031)
8.2 Asia-Pacific Antipsychotic Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antipsychotic Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Antipsychotic Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antipsychotic Medicine Market Size (2020-2031)
9.2 Latin America Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antipsychotic Medicine Market Size by Country (2020-2025)
9.4 Latin America Antipsychotic Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Medicine Market Size (2020-2031)
10.2 Middle East & Africa Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antipsychotic Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Antipsychotic Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Antipsychotic Medicine Introduction
11.1.4 Johnson and Johnson Revenue in Antipsychotic Medicine Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Antipsychotic Medicine Introduction
11.2.4 Eli Lilly Revenue in Antipsychotic Medicine Business (2020-2025)
11.2.5 Eli Lilly Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Introduction
11.3.4 Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antipsychotic Medicine Introduction
11.4.4 AstraZeneca Revenue in Antipsychotic Medicine Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antipsychotic Medicine Introduction
11.5.4 Novartis Revenue in Antipsychotic Medicine Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Antipsychotic Medicine Introduction
11.6.4 Allergan Revenue in Antipsychotic Medicine Business (2020-2025)
11.6.5 Allergan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antipsychotic Medicine Introduction
11.7.4 Pfizer Revenue in Antipsychotic Medicine Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Antipsychotic Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Otsuka Pharma
11.9.1 Otsuka Pharma Company Details
11.9.2 Otsuka Pharma Business Overview
11.9.3 Otsuka Pharma Antipsychotic Medicine Introduction
11.9.4 Otsuka Pharma Revenue in Antipsychotic Medicine Business (2020-2025)
11.9.5 Otsuka Pharma Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Antipsychotic Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2020-2025)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Alkermes
11.11.1 Alkermes Company Details
11.11.2 Alkermes Business Overview
11.11.3 Alkermes Antipsychotic Medicine Introduction
11.11.4 Alkermes Revenue in Antipsychotic Medicine Business (2020-2025)
11.11.5 Alkermes Recent Development
11.12 Vanda Pharma
11.12.1 Vanda Pharma Company Details
11.12.2 Vanda Pharma Business Overview
11.12.3 Vanda Pharma Antipsychotic Medicine Introduction
11.12.4 Vanda Pharma Revenue in Antipsychotic Medicine Business (2020-2025)
11.12.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipsychotic Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Antipsychotics
1.2.3 Injectable Antipsychotics
1.3 Market by Application
1.3.1 Global Antipsychotic Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Clinic Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Medicine Market Perspective (2020-2031)
2.2 Global Antipsychotic Medicine Growth Trends by Region
2.2.1 Global Antipsychotic Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antipsychotic Medicine Historic Market Size by Region (2020-2025)
2.2.3 Antipsychotic Medicine Forecasted Market Size by Region (2026-2031)
2.3 Antipsychotic Medicine Market Dynamics
2.3.1 Antipsychotic Medicine Industry Trends
2.3.2 Antipsychotic Medicine Market Drivers
2.3.3 Antipsychotic Medicine Market Challenges
2.3.4 Antipsychotic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipsychotic Medicine Players by Revenue
3.1.1 Global Top Antipsychotic Medicine Players by Revenue (2020-2025)
3.1.2 Global Antipsychotic Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Antipsychotic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antipsychotic Medicine Revenue
3.4 Global Antipsychotic Medicine Market Concentration Ratio
3.4.1 Global Antipsychotic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Medicine Revenue in 2024
3.5 Global Key Players of Antipsychotic Medicine Head office and Area Served
3.6 Global Key Players of Antipsychotic Medicine, Product and Application
3.7 Global Key Players of Antipsychotic Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Medicine Breakdown Data by Type
4.1 Global Antipsychotic Medicine Historic Market Size by Type (2020-2025)
4.2 Global Antipsychotic Medicine Forecasted Market Size by Type (2026-2031)
5 Antipsychotic Medicine Breakdown Data by Application
5.1 Global Antipsychotic Medicine Historic Market Size by Application (2020-2025)
5.2 Global Antipsychotic Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antipsychotic Medicine Market Size (2020-2031)
6.2 North America Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antipsychotic Medicine Market Size by Country (2020-2025)
6.4 North America Antipsychotic Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antipsychotic Medicine Market Size (2020-2031)
7.2 Europe Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antipsychotic Medicine Market Size by Country (2020-2025)
7.4 Europe Antipsychotic Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Medicine Market Size (2020-2031)
8.2 Asia-Pacific Antipsychotic Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antipsychotic Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Antipsychotic Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antipsychotic Medicine Market Size (2020-2031)
9.2 Latin America Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antipsychotic Medicine Market Size by Country (2020-2025)
9.4 Latin America Antipsychotic Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Medicine Market Size (2020-2031)
10.2 Middle East & Africa Antipsychotic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antipsychotic Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Antipsychotic Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Antipsychotic Medicine Introduction
11.1.4 Johnson and Johnson Revenue in Antipsychotic Medicine Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Antipsychotic Medicine Introduction
11.2.4 Eli Lilly Revenue in Antipsychotic Medicine Business (2020-2025)
11.2.5 Eli Lilly Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Introduction
11.3.4 Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antipsychotic Medicine Introduction
11.4.4 AstraZeneca Revenue in Antipsychotic Medicine Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antipsychotic Medicine Introduction
11.5.4 Novartis Revenue in Antipsychotic Medicine Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Antipsychotic Medicine Introduction
11.6.4 Allergan Revenue in Antipsychotic Medicine Business (2020-2025)
11.6.5 Allergan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antipsychotic Medicine Introduction
11.7.4 Pfizer Revenue in Antipsychotic Medicine Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Antipsychotic Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Otsuka Pharma
11.9.1 Otsuka Pharma Company Details
11.9.2 Otsuka Pharma Business Overview
11.9.3 Otsuka Pharma Antipsychotic Medicine Introduction
11.9.4 Otsuka Pharma Revenue in Antipsychotic Medicine Business (2020-2025)
11.9.5 Otsuka Pharma Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Antipsychotic Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2020-2025)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Alkermes
11.11.1 Alkermes Company Details
11.11.2 Alkermes Business Overview
11.11.3 Alkermes Antipsychotic Medicine Introduction
11.11.4 Alkermes Revenue in Antipsychotic Medicine Business (2020-2025)
11.11.5 Alkermes Recent Development
11.12 Vanda Pharma
11.12.1 Vanda Pharma Company Details
11.12.2 Vanda Pharma Business Overview
11.12.3 Vanda Pharma Antipsychotic Medicine Introduction
11.12.4 Vanda Pharma Revenue in Antipsychotic Medicine Business (2020-2025)
11.12.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antipsychotic Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Antipsychotics
Table 3. Key Players of Injectable Antipsychotics
Table 4. Global Antipsychotic Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antipsychotic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antipsychotic Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antipsychotic Medicine Market Share by Region (2020-2025)
Table 8. Global Antipsychotic Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antipsychotic Medicine Market Share by Region (2026-2031)
Table 10. Antipsychotic Medicine Market Trends
Table 11. Antipsychotic Medicine Market Drivers
Table 12. Antipsychotic Medicine Market Challenges
Table 13. Antipsychotic Medicine Market Restraints
Table 14. Global Antipsychotic Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antipsychotic Medicine Market Share by Players (2020-2025)
Table 16. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2024)
Table 17. Ranking of Global Top Antipsychotic Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antipsychotic Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antipsychotic Medicine, Headquarters and Area Served
Table 20. Global Key Players of Antipsychotic Medicine, Product and Application
Table 21. Global Key Players of Antipsychotic Medicine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antipsychotic Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antipsychotic Medicine Revenue Market Share by Type (2020-2025)
Table 25. Global Antipsychotic Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antipsychotic Medicine Revenue Market Share by Type (2026-2031)
Table 27. Global Antipsychotic Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antipsychotic Medicine Revenue Market Share by Application (2020-2025)
Table 29. Global Antipsychotic Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antipsychotic Medicine Revenue Market Share by Application (2026-2031)
Table 31. North America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antipsychotic Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antipsychotic Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antipsychotic Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson and Johnson Company Details
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson Antipsychotic Medicine Product
Table 49. Johnson and Johnson Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. Eli Lilly Company Details
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Antipsychotic Medicine Product
Table 54. Eli Lilly Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Antipsychotic Medicine Product
Table 59. Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Antipsychotic Medicine Product
Table 64. AstraZeneca Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Antipsychotic Medicine Product
Table 69. Novartis Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Antipsychotic Medicine Product
Table 74. Allergan Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Antipsychotic Medicine Product
Table 79. Pfizer Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Antipsychotic Medicine Product
Table 84. GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Otsuka Pharma Company Details
Table 87. Otsuka Pharma Business Overview
Table 88. Otsuka Pharma Antipsychotic Medicine Product
Table 89. Otsuka Pharma Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 90. Otsuka Pharma Recent Development
Table 91. Sumitomo Dainippon Company Details
Table 92. Sumitomo Dainippon Business Overview
Table 93. Sumitomo Dainippon Antipsychotic Medicine Product
Table 94. Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 95. Sumitomo Dainippon Recent Development
Table 96. Alkermes Company Details
Table 97. Alkermes Business Overview
Table 98. Alkermes Antipsychotic Medicine Product
Table 99. Alkermes Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 100. Alkermes Recent Development
Table 101. Vanda Pharma Company Details
Table 102. Vanda Pharma Business Overview
Table 103. Vanda Pharma Antipsychotic Medicine Product
Table 104. Vanda Pharma Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 105. Vanda Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Antipsychotic Medicine Picture
Figure 2. Global Antipsychotic Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antipsychotic Medicine Market Share by Type: 2024 VS 2031
Figure 4. Oral Antipsychotics Features
Figure 5. Injectable Antipsychotics Features
Figure 6. Global Antipsychotic Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antipsychotic Medicine Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Clinic Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Antipsychotic Medicine Report Years Considered
Figure 12. Global Antipsychotic Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Antipsychotic Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antipsychotic Medicine Market Share by Region: 2024 VS 2031
Figure 15. Global Antipsychotic Medicine Market Share by Players in 2024
Figure 16. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Antipsychotic Medicine Revenue in 2024
Figure 18. North America Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 20. United States Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 24. Germany Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antipsychotic Medicine Market Share by Region (2020-2031)
Figure 32. China Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 40. Mexico Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 44. Turkey Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Johnson and Johnson Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 48. Eli Lilly Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 50. AstraZeneca Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 52. Allergan Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 55. Otsuka Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 56. Sumitomo Dainippon Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 57. Alkermes Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 58. Vanda Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Antipsychotic Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Antipsychotics
Table 3. Key Players of Injectable Antipsychotics
Table 4. Global Antipsychotic Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antipsychotic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antipsychotic Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antipsychotic Medicine Market Share by Region (2020-2025)
Table 8. Global Antipsychotic Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antipsychotic Medicine Market Share by Region (2026-2031)
Table 10. Antipsychotic Medicine Market Trends
Table 11. Antipsychotic Medicine Market Drivers
Table 12. Antipsychotic Medicine Market Challenges
Table 13. Antipsychotic Medicine Market Restraints
Table 14. Global Antipsychotic Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antipsychotic Medicine Market Share by Players (2020-2025)
Table 16. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2024)
Table 17. Ranking of Global Top Antipsychotic Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antipsychotic Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antipsychotic Medicine, Headquarters and Area Served
Table 20. Global Key Players of Antipsychotic Medicine, Product and Application
Table 21. Global Key Players of Antipsychotic Medicine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antipsychotic Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antipsychotic Medicine Revenue Market Share by Type (2020-2025)
Table 25. Global Antipsychotic Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antipsychotic Medicine Revenue Market Share by Type (2026-2031)
Table 27. Global Antipsychotic Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antipsychotic Medicine Revenue Market Share by Application (2020-2025)
Table 29. Global Antipsychotic Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antipsychotic Medicine Revenue Market Share by Application (2026-2031)
Table 31. North America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antipsychotic Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antipsychotic Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antipsychotic Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antipsychotic Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antipsychotic Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson and Johnson Company Details
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson Antipsychotic Medicine Product
Table 49. Johnson and Johnson Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. Eli Lilly Company Details
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Antipsychotic Medicine Product
Table 54. Eli Lilly Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Antipsychotic Medicine Product
Table 59. Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Antipsychotic Medicine Product
Table 64. AstraZeneca Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Antipsychotic Medicine Product
Table 69. Novartis Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Antipsychotic Medicine Product
Table 74. Allergan Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Antipsychotic Medicine Product
Table 79. Pfizer Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Antipsychotic Medicine Product
Table 84. GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Otsuka Pharma Company Details
Table 87. Otsuka Pharma Business Overview
Table 88. Otsuka Pharma Antipsychotic Medicine Product
Table 89. Otsuka Pharma Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 90. Otsuka Pharma Recent Development
Table 91. Sumitomo Dainippon Company Details
Table 92. Sumitomo Dainippon Business Overview
Table 93. Sumitomo Dainippon Antipsychotic Medicine Product
Table 94. Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 95. Sumitomo Dainippon Recent Development
Table 96. Alkermes Company Details
Table 97. Alkermes Business Overview
Table 98. Alkermes Antipsychotic Medicine Product
Table 99. Alkermes Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 100. Alkermes Recent Development
Table 101. Vanda Pharma Company Details
Table 102. Vanda Pharma Business Overview
Table 103. Vanda Pharma Antipsychotic Medicine Product
Table 104. Vanda Pharma Revenue in Antipsychotic Medicine Business (2020-2025) & (US$ Million)
Table 105. Vanda Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Antipsychotic Medicine Picture
Figure 2. Global Antipsychotic Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antipsychotic Medicine Market Share by Type: 2024 VS 2031
Figure 4. Oral Antipsychotics Features
Figure 5. Injectable Antipsychotics Features
Figure 6. Global Antipsychotic Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antipsychotic Medicine Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Clinic Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Antipsychotic Medicine Report Years Considered
Figure 12. Global Antipsychotic Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Antipsychotic Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antipsychotic Medicine Market Share by Region: 2024 VS 2031
Figure 15. Global Antipsychotic Medicine Market Share by Players in 2024
Figure 16. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Antipsychotic Medicine Revenue in 2024
Figure 18. North America Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 20. United States Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 24. Germany Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antipsychotic Medicine Market Share by Region (2020-2031)
Figure 32. China Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 40. Mexico Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antipsychotic Medicine Market Share by Country (2020-2031)
Figure 44. Turkey Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Antipsychotic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Johnson and Johnson Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 48. Eli Lilly Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 50. AstraZeneca Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 52. Allergan Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 55. Otsuka Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 56. Sumitomo Dainippon Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 57. Alkermes Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 58. Vanda Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232